Congo vs Mongolia: Estimated antiretroviral therapy coverage among people living with HIV
Congo
35.0%
in 2025
Mongolia
42.0%
in 2025
Congo rank
135th
Mongolia rank
132nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Congo
- Mongolia
How they compare
Mongolia currently reports 42.0% against 35.0% in Congo, a difference of 7.0%.
That makes Mongolia's figure about 1.2 times Congo's.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Mongolia ahead.
Congo ranks 135th and Mongolia ranks 132nd of 143 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Mongolia in 2.
Head to head by decade
| Decade | Congo | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 0.7% | 3.0% | Congo |
| 2010s | 19.8% | 22.9% | 3.1% | Mongolia |
| 2020s | 29.5% | 39.3% | 9.8% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Congo or Mongolia?
- Mongolia, at 42.0% against 35.0% in Congo as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Congo and Mongolia?
- 7.0%, with Mongolia ahead.
- How many years of comparable data are there for Congo and Mongolia?
- 26 years are reported by both, from 2000 to 2025.
- How do Congo and Mongolia rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Congo ranks 135th and Mongolia ranks 132nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.